SeaCrest Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,036
Closed -$348K 678
2022
Q2
$348K Buy
11,036
+6,208
+129% +$217K 0.04% 433
2022
Q1
$222K Buy
4,828
+505
+12% +$24.1K 0.03% 621
2021
Q4
$265K Sell
4,323
-238
-5% -$16.5K 0.03% 552
2021
Q3
$341K Buy
4,561
+2,041
+81% +$171K 0.04% 461
2021
Q2
$233K Sell
2,520
-4,763
-65% -$405K 0.03% 585
2021
Q1
$646K Buy
7,283
+1,018
+16% +$101K 0.09% 252
2020
Q4
$584K Sell
6,265
-754
-11% -$60.1K 0.08% 256
2020
Q3
$447K Sell
7,019
-1,355
-16% -$79.4K 0.07% 272
2020
Q2
$437K Sell
8,374
-7,948
-49% -$341K 0.08% 276
2020
Q1
$511K Sell
16,322
-2,608
-14% -$87.1K 0.11% 204
2019
Q4
$635K Sell
18,930
-6,118
-24% -$194K 0.11% 226
2019
Q3
$739K Sell
25,048
-8,958
-26% -$291K 0.14% 189
2019
Q2
$1.17M Buy
34,006
+16,678
+96% +$535K 0.24% 96
2019
Q1
$570K Sell
17,328
-2,380
-12% -$70.3K 0.1% 207
2018
Q4
$473K Sell
19,708
-7,433
-27% -$209K 0.1% 215
2018
Q3
$907K Buy
27,141
+5,054
+23% +$160K 0.15% 135
2018
Q2
$642K Buy
+22,087
New +$615K 0.12% 187

Other funds holding ARKG

SeaCrest Wealth Management's ARKG Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 11,036 shares — an estimated $348K sold.

SeaCrest Wealth Management first reported a position in ARKG in Q2 2018 and held it in 17 quarters. The position peaked at $1.17M in Q2 2019. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

  • SeaCrest Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
  • SeaCrest Wealth Management sold 11,036 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $348K.
  • SeaCrest Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2018 and held it in 17 quarters.
  • SeaCrest Wealth Management's ARK Genomic Revolution ETF position peaked at $1.17M in Q2 2019.
  • 311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.